Furthermore, disruption of mitochondrial function due to deficiency of the mitochondrial transcription factor A (TFAM) gene could decrease tumorigenesis in an oncogenic Kras-driven mouse model of lung cancer (12). This evidence concerns the gene TFAM and lung carcinoma.